AMDL, Inc. Re-Elects Its Board of Directors
September 30 2008 - 9:30AM
PR Newswire (US)
TUSTIN, Calif., Sept. 30 /PRNewswire-FirstCall/ --
(http://www.amdl.com/) AMDL, Inc. (AMEX:ADL), a leading vertically
integrated bio-pharmaceutical company with major operations in
China and the US, announced today at its annual meeting of
shareholders that is has re-elected the existing members of its
Board of Directors, including Dr. Bill Thompson, Dr. Edward
Arquilla, Mr. Henry Jai, Mr. Gary Dreher and Mr. Doug MacLellan to
the Company's Board of Directors for the fiscal year 2008.
Long-time board member Dr. Bill Thompson is retiring from his
position as Chairman of the Board of the Directors and will assume
responsibilities as Chairman of the Governance Committee. Mr.
Douglas MacLellan has been appointed AMDL's new Chairman of the
Board serving as the Company's lead spokesperson and support
resource to AMDL's executive management team. Mr. MacLellan will
continue serving as Chairman of the Audit Committee. Dr. Arquilla
has been newly appointed as Chairman of the Compensation Committee.
There have been no changes to the Company's executive management
team. About AMDL: Headquartered in Tustin, CA with operations in
Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its
subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically
integrated bio-pharmaceutical company devoted to the research,
development, manufacturing, and marketing of diagnostic,
pharmaceutical, nutritional supplement, and cosmetic products. The
company employs approximately 320 people in the U.S. and China. The
Company has an additional 4 pharmaceutical and diagnostic products
under review by various regulatory authorities. Forward Looking
Statements: Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995: The statements contained in this
document include certain predictions and projections that may be
considered forward-looking statements under securities law. These
statements involve a number of important risks and uncertainties
that could cause actual results to differ materially including, but
not limited to, the performance of joint venture partners, as well
as other economic, competitive and technological factors involving
the Company's operations, markets, services, products, and prices.
With respect to AMDL Inc., except for the historical information
contained herein, the matters discussed in this document are
forward-looking statements involving risks and uncertainties that
could cause actual results to differ materially from those in such
forward-looking statements. Potential risks and uncertainties
related to the Company's access to additional capital, competition
and dependence on key management. Kristine Szarkowitz
Director-Investor Relations (M) (206) 310-5323 DATASOURCE: AMDL,
Inc. CONTACT: Kristine Szarkowitz, Director, Investor Relations of
AMDL, Inc., +1-206-310-5323, Web site: http://www.amdl.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From May 2024 to Jun 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2023 to Jun 2024